We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.
- Authors
Mitrovic, Zdravko; Bast, Martin; Bierman, Philip J.; Bociek, Robert G.; Vose, Julie M.; Chan, Wing C.; Armitage, James O.
- Abstract
The article discusses the addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma. It states that secondary central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) is an infrequent but almost always fatal complication.
- Subjects
CENTRAL nervous system; RITUXIMAB; ANTINEOPLASTIC agents; MONOCLONAL antibodies; B cells
- Publication
British Journal of Haematology, 2012, Vol 157, Issue 3, p401
- ISSN
0007-1048
- Publication type
Article
- DOI
10.1111/j.1365-2141.2011.08998.x